Invention Grant
- Patent Title: Processes for preparing a MDM2 inhibitor
-
Application No.: US17272031Application Date: 2019-08-30
-
Publication No.: US11753386B2Publication Date: 2023-09-12
- Inventor: Sebastien Caille , Michael Corbett , Austin Smith
- Applicant: Amgen, Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen, Inc.
- Current Assignee: Amgen, Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2019/049087 2019.08.30
- International Announcement: WO2020/047424A 2020.03.05
- Date entered country: 2021-02-26
- Main IPC: C07D263/14
- IPC: C07D263/14 ; C07D211/76
Abstract:
The present invention provides commercial processes for preparing 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid as well as intermediates thereof.
Public/Granted literature
- US20210347743A1 Processes for Preparing a MDM2 Inhibitor Public/Granted day:2021-11-11
Information query
